From Our 2012 Archives
Voraxaze Approved to Treat High Levels of Chemo Drug
Latest Cancer News
While methotrexate is normally removed from the blood by the kidneys, people who are prescribed high levels of methotrexate may develop kidney failure, leading to a buildup of the drug in the bloodstream.
Voraxaze is an enzyme that breaks down methotrexate into a form that is more easily eliminated from the body, the FDA said in a news release.
Voraxaze was evaluated in a clinical trial of 22 people. Ten of the 22 participants saw blood methotrexate levels fall below a critical level within 15 minutes. Among all participants, Voraxaze eliminated 95 percent of methotrexate, the FDA said.
Voraxaze is marketed by BTG International of West Conshohocken, Penn.
-- Scott Roberts
Copyright © 2012 HealthDay. All rights reserved.